Viewing Study NCT00927602

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:44 AM
Ignite Modification Date: 2026-04-29 @ 10:55 AM
Study NCT ID: NCT00927602
Status: TERMINATED
Last Update Posted: 2012-04-24
First Post: 2009-06-24
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Fondaparinux 1,5 mg for the Prevention of Venous Thromboembolism (VTE) in Medical Patients With Renal Insufficiency
Sponsor: Università degli Studi dell'Insubria
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Medical Patients View
None Renal Insufficiency View
Keywords:

Keywords

Keyword Brief Keyword Text View
None renal failure View
None medical patient View
None venous thromboembolism View
None prophylaxis View
None fondaparinux View